Anticoagulation for Stroke Prevention after Restoration of Haemostasis with Emicizumab in Acquired Haemophilia A
Acquired haemophilia A (AHA) is a rare haemorrhagic disorder caused by the development of autoantibodies inhibiting factor VIII function. It predominantly affects the elderly, who are often burdened with a considerable number of comorbidities, and can result in life-threatening bleeding. The managem...
Guardado en:
Autores principales: | Kadhim Al-Banaa, Nicolas Gallastegui-Crestani, Annette von Drygalski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SMC MEDIA SRL
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4befdf7a71bc481082661ea7d450d9ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Avances en la prevención de eventos tromboembólicos en pacientes con fibrilación auricular
por: Montagna M,Rodrigo, et al.
Publicado: (2007) -
Use of anticoagulants in elderly patients: practical recommendations
por: Helia Robert-Ebadi, et al.
Publicado: (2009) -
Profilaxis de enfermedad tromboembólica en pacientes hospitalizados con patología médica, estrechando la brecha entre las guías y la práctica clínica
por: Aizman,Andrés, et al.
Publicado: (2011) -
Equivalent VTE rates after total joint arthroplasty using thromboprophylaxis with aspirin versus potent anticoagulants: retrospective analysis of 4562 cases across a diverse healthcare system
por: Chelsea Matzko, et al.
Publicado: (2021) -
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin A
Publicado: (2013)